Nimbus Health is a technology company.
Nimbus Health has raised $12.0M across 1 funding round.
Nimbus Health has raised $12.0M in total across 1 funding round.
Nimbus Health has raised $12.0M in total across 1 funding round.
Nimbus Health's investors include 2048 Ventures, Alumni Ventures, Scale Asia Ventures.
Nimbus Health is a venture-backed technology company operating a network of pulmonary clinics that leverages AI, machine learning, and telehealth to deliver proactive care for chronic respiratory diseases like COPD, asthma, and sleep apnea.[1][3][4][7] It serves patients with lung conditions through advanced vitals monitoring, digital-first rehabilitation programs, smoking cessation support, and a blend of virtual and in-clinic services, accepting all major insurers to address access barriers in pulmonary medicine.[1][3] The company solves fragmented respiratory care by integrating predictive modeling with clinical expertise, enabling early risk detection and data-informed interventions that improve outcomes and practice efficiency for partnered clinics.[1][3][4]
Growth momentum is strong, evidenced by partnerships like the June 2025 collaboration with Century Health to create AI-powered clinical registries for COPD and asthma research, Silicon Valley venture backing from investors including those tied to 8VC, and expansion via clinic partnerships that add revenue streams like panel growth and new service lines.[3][4][7]
Nimbus Health emerged from a mission to reinvent pulmonary care using technology in a sector resistant to innovation, starting as a venture-backed entity with funding from Silicon Valley investors focused on tech-driven healthcare.[4][7] Key team members include James Barfield, a machine learning engineer with 15+ years at firms like Verizon and Medtronic, who guides the tech platform; Cari Grisham, an operations leader experienced in AI remote monitoring from 100Plus; and Gautam Chebrolu, a product builder and cofounder of digital health startup Pilleve, honored on Forbes 30 Under 30.[5] Early traction came from transforming traditional clinics—adding service lines for chronically ill, older patients and boosting revenues through data science and operational reinvention—leading to scalable partnerships and national expansion from locations like Columbus, Georgia.[1][4][5]
Nimbus Health rides the wave of AI-augmented healthcare, particularly in chronic disease management amid rising respiratory burdens from aging populations and post-pandemic awareness.[1][3] Timing aligns with telehealth normalization, real-world evidence demands for drug development, and investor interest in value-based care models that cut costs via prevention.[3][4][7] Market forces like insurer pressures for efficiency and clinic staffing shortages favor its tech-enabled scaling, influencing the ecosystem by creating research-grade datasets that accelerate therapies and by partnering with independents to compete against consolidators.[3][4] As a 8VC portfolio company, it exemplifies VC bets on clinician-tech hybrids reshaping specialty care.[7]
Nimbus Health is poised to expand its clinic network and AI capabilities, potentially broadening beyond pulmonology into adjacent chronic areas via data partnerships like Century Health.[3][4] Trends in AI real-world evidence, remote monitoring, and personalized medicine will propel growth, especially as regulations evolve to support tech-clinician models. Its influence may grow by standardizing data-driven pulmonary care nationwide, empowering more practices and research, ultimately redefining respiratory health from reactive to predictive—building on its tech roots to lead innovation in a high-need field.[1][3][5][7]
Nimbus Health has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Seed in May 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2025 | $12.0M Seed | 2048 Ventures, Alumni Ventures, Scale Asia Ventures |